Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DDL86V
|
|||
| Drug Name |
MGTA-145
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 2 | [1] | |
| Company |
Magenta Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04762875) MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.